NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 197 filers reported holding NEVRO CORP in Q3 2021. The put-call ratio across all filers is 2.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $451,670 | -15.0% | 23,500 | +12.4% | 0.00% | -20.0% |
| Q2 2023 | $531,278 | +126.1% | 20,900 | +221.5% | 0.01% | +150.0% |
| Q1 2023 | $234,975 | -10.1% | 6,500 | -1.5% | 0.00% | -33.3% |
| Q4 2022 | $261,360 | -31.6% | 6,600 | -19.5% | 0.00% | -25.0% |
| Q3 2022 | $382,120 | -39.2% | 8,200 | -5.7% | 0.00% | -33.3% |
| Q1 2022 | $629,000 | +14.2% | 8,700 | +27.9% | 0.01% | +50.0% |
| Q4 2021 | $551,000 | -16.9% | 6,800 | +19.3% | 0.00% | -42.9% |
| Q3 2021 | $663,000 | +48.0% | 5,700 | +111.1% | 0.01% | +75.0% |
| Q2 2021 | $448,000 | +52.9% | 2,700 | +28.6% | 0.00% | +33.3% |
| Q1 2021 | $293,000 | -39.6% | 2,100 | -25.0% | 0.00% | -40.0% |
| Q4 2020 | $485,000 | -58.5% | 2,800 | -66.7% | 0.01% | -61.5% |
| Q3 2020 | $1,170,000 | +112.7% | 8,400 | +82.6% | 0.01% | +116.7% |
| Q2 2020 | $550,000 | +41.0% | 4,600 | +17.9% | 0.01% | +20.0% |
| Q1 2020 | $390,000 | +57.9% | 3,900 | +85.7% | 0.01% | +66.7% |
| Q4 2019 | $247,000 | – | 2,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engaged Capital LLC | 1,885,956 | $15,879,750 | 2.72% |
| Kent Lake Capital LLC | 639,775 | $5,386,906 | 2.43% |
| Wellington Wealth Strategies, LLC. | 71 | $538,662 | 2.26% |
| Palo Alto Investors LP | 750,371 | $6,318,124 | 0.73% |
| BRAIDWELL LP | 1,698,768 | $14,303,627 | 0.45% |
| ArrowMark Colorado Holdings LLC | 4,289,108 | $36,114,289 | 0.43% |
| ARMISTICE CAPITAL, LLC | 3,672,000 | $30,918,240 | 0.39% |
| Rock Springs Capital Management LP | 1,381,500 | $11,632,230 | 0.35% |
| Eversept Partners, LP | 499,395 | $4,204,906 | 0.29% |
| Olympiad Research LP | 25,046 | $210,887 | 0.16% |